BACKGROUND: Limited literature exists on the association between medication adherence and outcomes among patients with heart failure. METHODS AND RESULTS: We conducted a retrospective longitudinal cohort study of 557 patients with heart failure with reduced ejection fraction (HFrEF) (defined by EF <50%) in a large health maintenance organization. We used multivariable Cox proportional hazards models to assess the relationship between adherence (with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, and aldosterone antagonists) and the primary outcome of all-cause mortality plus cardiovascular hospitalizations. Mean follow-up time was 1.1 years. Nonadherence (defined as <80% adherence) was associated with a statistically significant increase in the primary outcome in the cohort overall (hazard ratio 2.07, 95% confidence interval 1.62-2.64; P < .0001). This association remained significant when all 3 classes of heart failure medications and the components of the composite end point were considered separately and when the adherence threshold was varied to 70% or 90%. CONCLUSIONS: Medication nonadherence was associated with an increased risk of all-cause mortality and cardiovascular hospitalizations in a community heart failure population. Further research is needed to define systems of care that optimize adherence among patients with heart failure.
BACKGROUND: Limited literature exists on the association between medication adherence and outcomes among patients with heart failure. METHODS AND RESULTS: We conducted a retrospective longitudinal cohort study of 557 patients with heart failure with reduced ejection fraction (HFrEF) (defined by EF <50%) in a large health maintenance organization. We used multivariable Cox proportional hazards models to assess the relationship between adherence (with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, and aldosterone antagonists) and the primary outcome of all-cause mortality plus cardiovascular hospitalizations. Mean follow-up time was 1.1 years. Nonadherence (defined as <80% adherence) was associated with a statistically significant increase in the primary outcome in the cohort overall (hazard ratio 2.07, 95% confidence interval 1.62-2.64; P < .0001). This association remained significant when all 3 classes of heart failure medications and the components of the composite end point were considered separately and when the adherence threshold was varied to 70% or 90%. CONCLUSIONS: Medication nonadherence was associated with an increased risk of all-cause mortality and cardiovascular hospitalizations in a community heart failure population. Further research is needed to define systems of care that optimize adherence among patients with heart failure.
Authors: Barbara Riegel; Christopher S Lee; Sarah J Ratcliffe; Sabina De Geest; Sheryl Potashnik; Megan Patey; Steven L Sayers; Lee R Goldberg; William S Weintraub Journal: Circ Heart Fail Date: 2012-05-30 Impact factor: 8.790
Authors: Shivan J Mehta; Kevin G Volpp; David A Asch; Lee R Goldberg; Louise B Russell; Laurie A Norton; Lauren G Iannotte; Andrea B Troxel Journal: Circ Cardiovasc Qual Outcomes Date: 2019-04
Authors: Susan J Pressler; Alison Martineau; Judith Grossi; Bruno Giordani; Todd M Koelling; David L Ronis; Penny L Riley; Cheng-Chen Chou; Barbara J Sullivan; Dean G Smith Journal: Heart Lung Date: 2013-07-01 Impact factor: 2.210
Authors: Elena-Laura Antohi; Andrew P Ambrosy; Sean P Collins; Ali Ahmed; Vlad Anton Iliescu; Gad Cotter; Peter S Pang; Javed Butler; Ovidiu Chioncel Journal: Am J Ther Date: 2019 Mar/Apr Impact factor: 2.688
Authors: Michael L Alosco; Mary Beth Spitznagel; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Manfred van Dulmen; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Clin Nurs Date: 2013-05-08 Impact factor: 3.036
Authors: Sunil Kripalani; Kathryn Goggins; Sam Nwosu; Jonathan Schildcrout; Amanda S Mixon; Candace McNaughton; Amanda M McDougald Scott; Kenneth A Wallston Journal: J Health Commun Date: 2015
Authors: Emily C Gathright; Mary A Dolansky; John Gunstad; Joseph D Redle; Richard A Josephson; Shirley M Moore; Joel W Hughes Journal: Health Psychol Date: 2017-07-20 Impact factor: 4.267